Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $201,170 | 47 | 64.9% |
| Honoraria | $94,735 | 19 | 30.6% |
| Travel and Lodging | $10,809 | 50 | 3.5% |
| Food and Beverage | $2,407 | 71 | 0.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $699.00 | 1 | 0.2% |
| Education | $10.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $307,348 | 166 | $0 (2024) |
| Pacira CryoTech Incorporated | $2,115 | 1 | $0 (2019) |
| Horizon Therapeutics plc | $79.85 | 5 | $0 (2020) |
| Allergan Inc. | $61.91 | 4 | $0 (2019) |
| Horizon Pharma plc | $51.76 | 4 | $0 (2018) |
| Myoscience Inc. | $50.88 | 1 | $0 (2018) |
| Amgen Inc. | $29.46 | 2 | $0 (2018) |
| GE HEALTHCARE | $26.28 | 1 | $0 (2019) |
| Purdue Pharma L.P. | $15.23 | 1 | $0 (2017) |
| Lilly USA, LLC | $14.04 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $60,602 | 29 | Pacira Pharmaceuticals Incorporated ($60,602) |
| 2023 | $151,176 | 53 | Pacira Pharmaceuticals Incorporated ($151,176) |
| 2022 | $45,599 | 58 | Pacira Pharmaceuticals Incorporated ($45,599) |
| 2021 | $34,932 | 25 | Pacira Pharmaceuticals Incorporated ($34,932) |
| 2020 | $15,091 | 4 | Pacira Pharmaceuticals Incorporated ($15,040) |
| 2019 | $2,184 | 5 | Pacira CryoTech Incorporated ($2,115) |
| 2018 | $170.13 | 10 | Horizon Pharma plc ($51.76) |
| 2017 | $77.64 | 5 | Allergan Inc. ($48.37) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Consulting Fee | Cash or cash equivalent | $705.00 | General |
| Category: Pain Management | ||||||
| 11/14/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Consulting Fee | Cash or cash equivalent | $4,700.00 | General |
| Category: Pain Management | ||||||
| 11/14/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $333.66 | General |
| Category: Pain Management | ||||||
| 11/09/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Pain Management | ||||||
| 07/16/2024 | Pacira Pharmaceuticals Incorporated | — | Honoraria | Cash or cash equivalent | $8,660.00 | General |
| 06/18/2024 | Pacira Pharmaceuticals Incorporated | — | Honoraria | Cash or cash equivalent | $12,345.00 | General |
| 05/28/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Consulting Fee | Cash or cash equivalent | $5,640.00 | General |
| Category: Pain Management | ||||||
| 05/28/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $333.66 | General |
| Category: Pain Management | ||||||
| 05/28/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | Cash or cash equivalent | $7.52 | General |
| Category: Pain Management | ||||||
| 05/28/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | Cash or cash equivalent | $5.61 | General |
| Category: Pain Management | ||||||
| 05/23/2024 | Pacira Pharmaceuticals Incorporated | — | Honoraria | Cash or cash equivalent | $6,330.00 | General |
| 05/18/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $71.14 | General |
| Category: Pain Management | ||||||
| 05/18/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $38.93 | General |
| Category: Pain Management | ||||||
| 04/16/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Honoraria | Cash or cash equivalent | $6,470.00 | General |
| Category: Pain Management | ||||||
| 03/12/2024 | Pacira Pharmaceuticals Incorporated | — | Honoraria | Cash or cash equivalent | $2,075.00 | General |
| 03/03/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $67.94 | General |
| Category: Pain Management | ||||||
| 03/02/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | In-kind items and services | $248.57 | General |
| Category: Pain Management | ||||||
| 02/08/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Honoraria | Cash or cash equivalent | $1,775.00 | General |
| Category: Pain Management | ||||||
| 01/23/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Consulting Fee | Cash or cash equivalent | $5,640.00 | General |
| Category: Pain Management | ||||||
| 01/23/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $566.80 | General |
| Category: Pain Management | ||||||
| 01/23/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug), Iovera | Consulting Fee | Cash or cash equivalent | $470.00 | General |
| Category: Pain Management | ||||||
| 01/23/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Pain Management | ||||||
| 01/23/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Travel and Lodging | Cash or cash equivalent | $19.61 | General |
| Category: Pain Management | ||||||
| 01/16/2024 | Pacira Pharmaceuticals Incorporated | — | Honoraria | Cash or cash equivalent | $3,420.00 | General |
| 01/09/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug), Iovera, Zilretta | Consulting Fee | Cash or cash equivalent | $235.00 | General |
| Category: Pain Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 4,741 | 8,475 | $2.3M | $605,987 |
| 2022 | 31 | 4,128 | 7,801 | $2.0M | $532,024 |
| 2021 | 32 | 4,350 | 8,316 | $2.2M | $570,748 |
| 2020 | 31 | 3,916 | 7,549 | $1.7M | $512,167 |
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 333 | 3,220 | $681,377 | $194,606 | 28.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 730 | 1,064 | $262,726 | $72,276 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 397 | 552 | $185,009 | $51,375 | 27.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 305 | 305 | $133,775 | $35,680 | 26.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 247 | 264 | $122,925 | $35,050 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 401 | 529 | $124,875 | $32,223 | 25.8% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 368 | 377 | $108,003 | $30,079 | 27.8% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 194 | 194 | $176,958 | $26,393 | 14.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 274 | 287 | $87,453 | $25,024 | 28.6% |
| 95907 | Nerve conduction, 1-2 studies | Office | 2023 | 244 | 249 | $57,394 | $16,187 | 28.2% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 95 | 95 | $81,754 | $13,100 | 16.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 137 | 137 | $40,307 | $10,632 | 26.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 84 | 110 | $35,007 | $9,973 | 28.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 75 | 76 | $34,270 | $9,609 | 28.0% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 221 | 242 | $31,227 | $8,362 | 26.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 54 | 55 | $18,970 | $5,406 | 28.5% |
| 64624 | Destruction of nerve branches of knee using imaging guidance | Office | 2023 | 16 | 17 | $16,743 | $4,773 | 28.5% |
| 64640 | Destruction of peripheral nerve or branch | Office | 2023 | 16 | 51 | $32,093 | $4,575 | 14.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 93 | 93 | $17,477 | $4,167 | 23.8% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 21 | 21 | $11,451 | $3,163 | 27.6% |
| 72050 | X-ray of upper spine, 4-5 views | Office | 2023 | 72 | 72 | $9,644 | $2,641 | 27.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 65 | 67 | $9,804 | $2,282 | 23.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 39 | 42 | $7,191 | $1,862 | 25.9% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 40 | 49 | $7,838 | $1,825 | 23.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 110 | 187 | $3,270 | $1,074 | 32.9% |
About Dr. William Rogenmoser, D.O
Dr. William Rogenmoser, D.O is a Physical Medicine & Rehabilitation healthcare provider based in Alexandria, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2012. The National Provider Identifier (NPI) number assigned to this provider is 1902171176.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Rogenmoser, D.O has received a total of $309,831 in payments from pharmaceutical and medical device companies, with $60,602 received in 2024. These payments were reported across 189 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($201,170).
As a Medicare-enrolled provider, Rogenmoser has provided services to 17,135 Medicare beneficiaries, totaling 32,141 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Alexandria, LA
- Active Since 03/20/2012
- Last Updated 08/16/2016
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1902171176
Products in Payments
- Iovera (Device) $173,683
- Exparel (Drug) $50,704
- EXPAREL (Drug) $15,040
- Zilretta (Drug) $7,389
- IOVERA SYSTEM (Device) $2,115
- Iovera System (Device) $471.32
- DUEXIS (Drug) $131.61
- BOTOX NEURO REHAB (Drug) $48.37
- Prolia (Biological) $29.46
- BUTRANS (Drug) $15.23
- FORTEO (Drug) $14.04
- BOTOX (Biological) $13.54
- GELSYN 3 (Device) $12.75
- Hymovis (Device) $12.71
- XEOMIN (Biological) $12.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Alexandria
Dr. Abraham Cherrick, Md, MD
Physical Medicine & Rehabilitation — Payments: $109,796
Jay Freid, Md, MD
Physical Medicine & Rehabilitation — Payments: $10,501
Larry Doughty, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $3,109
Peter Yeh
Physical Medicine & Rehabilitation — Payments: $2,062
Carlos Perez Gonzalez, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,881
Jessalynn Adam, Md, MD
Physical Medicine & Rehabilitation — Payments: $1,030